DK3536346T3 - PET tracer til afbildning af neuroendocrine tumorer - Google Patents
PET tracer til afbildning af neuroendocrine tumorer Download PDFInfo
- Publication number
- DK3536346T3 DK3536346T3 DK19164889.8T DK19164889T DK3536346T3 DK 3536346 T3 DK3536346 T3 DK 3536346T3 DK 19164889 T DK19164889 T DK 19164889T DK 3536346 T3 DK3536346 T3 DK 3536346T3
- Authority
- DK
- Denmark
- Prior art keywords
- neuroendocrine tumors
- pet tracer
- imaging neuroendocrine
- imaging
- tracer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/083—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being octreotide or a somatostatin-receptor-binding peptide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nuclear Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201100654 | 2011-08-31 | ||
| EP12828526.9A EP2750717B1 (en) | 2011-08-31 | 2012-08-23 | Pet tracer for imaging of neuroendocrine tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3536346T3 true DK3536346T3 (da) | 2021-01-25 |
Family
ID=47755353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19164889.8T DK3536346T3 (da) | 2011-08-31 | 2012-08-23 | PET tracer til afbildning af neuroendocrine tumorer |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US10159759B2 (da) |
| EP (2) | EP3536346B1 (da) |
| DK (1) | DK3536346T3 (da) |
| ES (2) | ES2732823T3 (da) |
| HU (2) | HUE044625T2 (da) |
| PL (2) | PL2750717T3 (da) |
| WO (1) | WO2013029616A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2732823T3 (es) * | 2011-08-31 | 2019-11-26 | Somscan Aps | Trazador Pet para imágenes de tumores neuroendocrinos |
| EP2846826B1 (en) * | 2012-05-08 | 2018-07-25 | TRT Innovations APS | 177-Lu LABELED PEPTIDE FOR SITE-SPECIFIC uPAR-TARGETING |
| GB201219403D0 (en) * | 2012-10-29 | 2012-12-12 | Uni I Olso | Method for improved estimation of tracer uptake in physiological image volumes |
| ES2755804T3 (es) * | 2012-12-03 | 2020-04-23 | Curasight Aps | Péptidos marcados con un radionúclido que emite positrones para obtención de imágenes de PET del uPAR humana |
| WO2014169073A1 (en) | 2013-04-09 | 2014-10-16 | Massachusetts Institute Of Technology | Drug delivery polymer and uses thereof |
| US10111969B2 (en) * | 2014-09-17 | 2018-10-30 | Rigshospitalet | uPAR targeting peptide for use in peroperative optical imaging of invasive cancer |
| JP7084417B2 (ja) * | 2017-01-12 | 2022-06-14 | ラジオメディックス インコーポレイテッド | 放射性同位体にキレートされたオクトレオチド誘導体を用いるソマトスタチン受容体を過剰発現しているがん細胞の治療 |
| WO2019195890A1 (en) * | 2018-04-11 | 2019-10-17 | Clarity Pharmaceuticals Pty Ltd | Formulations and kits for radiotherapy and diagnostic imaging |
| CA3098492A1 (en) * | 2018-04-27 | 2019-12-19 | University Of Iowa Research Foundation | Compositions for chelating metals at low temperatures |
| TW202123975A (zh) | 2019-09-17 | 2021-07-01 | 義大利商先進艾斯雷特應用（義大利）公司 | 放射性標記grpr拮抗劑之方法及其套組 |
| CA3166142A1 (en) * | 2020-01-29 | 2021-08-05 | Dongyoul Lee | Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers |
| WO2021219720A1 (en) | 2020-04-29 | 2021-11-04 | Advanced Accelerator Applications (Italy) Srl | Methods for radiolabeling psma binding ligands and their kits |
| US20230330278A1 (en) | 2020-04-29 | 2023-10-19 | Novartis Ag | Methods for radiolabelling psma binding ligands and their kits |
| CN116583527A (zh) * | 2020-09-03 | 2023-08-11 | 库瑞姆美国有限责任公司 | 用于64Cu-DOTATATE放大规模的放射性标记和制剂 |
| US11541134B1 (en) | 2021-08-02 | 2023-01-03 | Rayzebio, Inc. | Stabilized compositions of radionuclides and uses thereof |
| EP4197561A1 (en) * | 2021-12-15 | 2023-06-21 | Curasight A/S | Urokinase-type plasminogen activator receptor (upar)-pet/ct in neuroendocrine neoplams |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7122622B2 (en) * | 2002-04-16 | 2006-10-17 | Biosynthema Inc. | Peptide compounds having improved binding affinity to somatostatin receptors |
| US20070025910A1 (en) | 2005-07-29 | 2007-02-01 | Norenberg Jeffrey P | Anticancer therapy |
| ES2732823T3 (es) * | 2011-08-31 | 2019-11-26 | Somscan Aps | Trazador Pet para imágenes de tumores neuroendocrinos |
-
2012
- 2012-08-23 ES ES12828526T patent/ES2732823T3/es active Active
- 2012-08-23 HU HUE12828526 patent/HUE044625T2/hu unknown
- 2012-08-23 ES ES19164889T patent/ES2842998T3/es active Active
- 2012-08-23 WO PCT/DK2012/050305 patent/WO2013029616A1/en active Application Filing
- 2012-08-23 PL PL12828526T patent/PL2750717T3/pl unknown
- 2012-08-23 PL PL19164889T patent/PL3536346T3/pl unknown
- 2012-08-23 HU HUE19164889A patent/HUE052723T2/hu unknown
- 2012-08-23 US US14/241,958 patent/US10159759B2/en active Active
- 2012-08-23 EP EP19164889.8A patent/EP3536346B1/en active Active
- 2012-08-23 DK DK19164889.8T patent/DK3536346T3/da active
- 2012-08-23 EP EP12828526.9A patent/EP2750717B1/en active Active
-
2018
- 2018-11-02 US US16/179,453 patent/US10383961B2/en active Active
-
2019
- 2019-06-27 US US16/454,631 patent/US11160888B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11160888B2 (en) | 2021-11-02 |
| HUE052723T2 (hu) | 2021-05-28 |
| US10383961B2 (en) | 2019-08-20 |
| US20140341807A1 (en) | 2014-11-20 |
| PL2750717T3 (pl) | 2019-11-29 |
| ES2842998T3 (es) | 2021-07-15 |
| EP3536346B1 (en) | 2020-10-28 |
| WO2013029616A1 (en) | 2013-03-07 |
| US20190083664A1 (en) | 2019-03-21 |
| EP2750717A4 (en) | 2015-03-04 |
| PL3536346T3 (pl) | 2021-07-19 |
| EP2750717A1 (en) | 2014-07-09 |
| US20190321497A1 (en) | 2019-10-24 |
| US10159759B2 (en) | 2018-12-25 |
| EP2750717B1 (en) | 2019-03-27 |
| EP3536346A1 (en) | 2019-09-11 |
| HUE044625T2 (hu) | 2019-11-28 |
| ES2732823T3 (es) | 2019-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3536346T3 (da) | PET tracer til afbildning af neuroendocrine tumorer | |
| CO7020871A2 (es) | Anticuerpos anti-il-36r | |
| DK3410725T3 (da) | Referencebilledsignalering | |
| DK2659675T3 (da) | Fremgangsmåde for billedsegmentering under anvendelse af søjler | |
| BR112013010351A2 (pt) | aparelho de formação de imagem | |
| BR112014010784A2 (pt) | pesquisa de determinação de espaço. | |
| DK3448034T3 (da) | Fremgangsmåde til at udlede bevægelsesinformation | |
| DK2788767T3 (da) | Fremgangsmåde til detektering af nukleosomaddukter | |
| BR112013001487A2 (pt) | método de criação de relatório de imagem | |
| BR112014000928A2 (pt) | aparelho de aquisição de informações de objeto | |
| DK2531526T3 (da) | Fremgangsmåde til opnåelse af antistoffer | |
| BR112014001383A2 (pt) | aparelho de formação de imagem | |
| DK3442228T3 (da) | Fremgangsmåde til billedafkodning | |
| DK2764405T3 (da) | Kamera | |
| DK3985979T3 (da) | Fremgangsmåde til bestemmelse af referenceenhed | |
| DK2876447T3 (da) | Fremgangsmåde til detektering af cancer | |
| DK2858563T3 (da) | Elektromedicinsk system til bestemmelse af neuromuskulkær lammelse | |
| DK3402201T3 (da) | Fremgangsmåde til dekodning af et billede | |
| DK3041576T3 (da) | Fremgangsmåder til at detektere nyresygdom | |
| DK2914739T3 (da) | Kombinationer af biomarkører for kolorektale tumorer | |
| FI20115703A (fi) | Näytteenotin | |
| BR112013033933A2 (pt) | aparelho de aquecimento de imagem | |
| DE102012213479A8 (de) | Positionsdetektor | |
| BR112013023694A2 (pt) | método de navegação de imagem 3d | |
| DK2734834T3 (da) | Røntgenbilleddannelse |